Peptides talk is everywhere: But what does the science say?

Here’s a situation scientist Katrin Svensson, PhD, never expected to find herself in: Molecules she discovered in the lab and tested (so far, only in mice) have shown up on internet-based company websites for anyone to purchase and use to inject themselves. These molecules.

But the craze is getting far ahead of the science in many ways, said Svensson, a Stanford Medicine associate professor of pathology. The peptides she’s discovered (including a new anti-obesity peptide, BRP) have not been tested in humans, a key first step between lab.

What Happened

Food and Drug Administration approval and clinical use, let alone been manufactured in a regulated, safe process for humans. And while her discoveries aren’t yet the subject of viral social media reels, many other research-grade — i.e., not for-human-use-grade — peptides are.

• Proteins tend to be a few hundred to over 1,000 amino acids long.

• Scientists have cataloged around 7,000 peptides in the human body, but it’s possible there are many more as yet undiscovered.

• It was discovered and isolated from a dog’s pancreas in 1921.

Key Details

In the name of looksmaxxing, muscle building, weight loss or just general wellness, many people trade tips and tricks on social media and inject themselves with unapproved peptides sourced from a variety of online companies through what is known as a gray.

• In 1982, it also became the first commercially available synthetically manufactured peptide.

• These combinations might prove more powerful for weight loss than GLP-1 alone or could have fewer side effects.

• Others, the experimental drugs retatrutide and cagrilintide-semaglutide, or CagriSema, combine a GLP-1 mimic with other metabolic peptides.

Why It Matters

With an FDA advisory panel recently voting to recommend loosening restrictions for compounding pharmacies on six peptides that are far from FDA approval, the picture is even murkier. Should the FDA take the panel’s recommendation, loosened restrictions would allow patients to get.

• Some, like the drug known as maridebart cafraglutide, or MariTide, combine a GLP-1 mimic with an antibody that may make it last longer in the body.

• Long and Svensson, who both study the roles of different peptides in metabolism, said that the peptide medications likely to be FDA approved the soonest are variations on GLP-1.

What Reports Say

Coverage of the story so far points to:

• Continued reporting by Stanford Medicine as more details emerge